Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Disease Cohort |
| ||
| Engaged Cohort |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observational | Other | Observational |
|
| Measure | Description | Time Frame |
|---|---|---|
| To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis | 20 Years | |
| To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease | 20 Years | |
| To establish learning health networks focused on quality of care for patients | 20 Years |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate provider management practices in the treatment of patients with CLD/Cirrhosis | 20 Years | |
| To evaluate longitudinal and patient reported outcomes in CLD/Cirrhosis | 20 Years |
Not provided
Inclusion Criteria:
Disease Cohort
•Adult* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface
Engaged Cohort
Exclusion Criteria:
Disease Cohort
Engaged Cohort
Not provided
Not provided
Not provided
The study will include adults who are being managed for chronic liver disease or cirrhosis of any etiology.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Keck School of Medicine of USC | Los Angeles | California | 90033 | United States | ||
| Stanford Medicine |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D057832 | Watchful Waiting |
| ID | Term |
|---|---|
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Whole blood Serum
| Redwood City |
| California |
| 94063 |
| United States |
| Georgetown Medstar Transplant Institute | Washington D.C. | District of Columbia | 20007 | United States |
| Rush University Medical Center | Chicago | Illinois | 60612 | United States |
| Columbia University Irving Medical Center/ New York Presbyterian Hospital | New York | New York | 10032 | United States |
| Atrium Health Center for Liver Disease and Transplant | Charlotte | North Carolina | 28204 | United States |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States |
| Temple University - Lewis Katz School of Medicine | Philadelphia | Pennsylvania | 19140 | United States |
| Baylor Scott & White Research Institute | Dallas | Texas | 75246 | United States |
| Baylor College of Medicine | Houston | Texas | 77021 | United States |